These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3371890)

  • 21. [Addition of ritanserin to the treatment with propranolol in cirrhotic patients: effects on portal pressure].
    Ladero Quesada JM; Díez Ordóñez S; Gallego Beuter JJ; Hernández Lezana A; Herraiz Serrano ML; Díaz-Rubio García M
    An Med Interna; 1994 Apr; 11(4):162-6. PubMed ID: 8043734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
    Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
    Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of propranolol in the patient with liver cirrhosis and hemorrhage caused by esophageal varices].
    Esquivel López A; López Fuertes F; Perches Vega A; Salgado-Escobar JL
    Rev Gastroenterol Mex; 1984; 49(4):211-4. PubMed ID: 6335774
    [No Abstract]   [Full Text] [Related]  

  • 24. [Behavior of blood ammonia, insulin, glucagon, renin and prolactin during propranolol therapy in cirrhosis patients with portal hypertension].
    Mazzone O; Randazzo G; Catalano D; Noè I
    Clin Ter; 1986 Jul; 118(2):109-14. PubMed ID: 3527539
    [No Abstract]   [Full Text] [Related]  

  • 25. [Physiopathological bases of the medical treatment of portal hypertension].
    Cuccurullo F; Seccia G; Porreca E; Guglielmi MD; Mezzetti A; Tomassetti V; Marzio L
    G Clin Med; 1982 Oct; 63(10):737-43. PubMed ID: 7182198
    [No Abstract]   [Full Text] [Related]  

  • 26. The low incidence of bacterial infections could be a protective factor against variceal bleeding per se in hemodynamic responders to propranolol.
    Senzolo M; Cholongitas E; Marelli L; Thalheimer U; Patch D; Burroughs AK
    Am J Gastroenterol; 2006 Oct; 101(10):2436-7. PubMed ID: 17032210
    [No Abstract]   [Full Text] [Related]  

  • 27. Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis.
    Ozsoylu S; Koçak N; Demir H; Yüce A; Gürakan F; Ozen H
    Turk J Pediatr; 2000; 42(1):31-3. PubMed ID: 10731866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effects of propranolol or nitroglycerin on azygos blood flow in patients with portal hypertension].
    Notsumata K
    Nihon Shokakibyo Gakkai Zasshi; 1986 Aug; 83(8):1489-97. PubMed ID: 3097355
    [No Abstract]   [Full Text] [Related]  

  • 29. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical treatment of portal hypertension and oesophageal varices.
    Cales P; Braillon A; Lebrec D
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1144. PubMed ID: 6414607
    [No Abstract]   [Full Text] [Related]  

  • 31. [New therapeutic possibilities of propranolol].
    Preobrazhenskiĭ DV
    Ter Arkh; 1984; 56(12):123-8. PubMed ID: 6084317
    [No Abstract]   [Full Text] [Related]  

  • 32. Betablocker, hepatic functions and confusion.
    Bhalla A
    J Assoc Physicians India; 1999 Feb; 47(2):254-5. PubMed ID: 10999112
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of hemorrhage from esophageal varices in patients with liver cirrhosis by administration of propranolol].
    López Fuerte F; Cárdenas Rojas JA; Esquivel López A; Perches Vega A
    Rev Gastroenterol Mex; 1986; 51(4):187-90. PubMed ID: 3502507
    [No Abstract]   [Full Text] [Related]  

  • 34. Does losartan work after all?
    Blendis LM; Wong F
    Am J Gastroenterol; 2003 Jun; 98(6):1222-4. PubMed ID: 12818261
    [No Abstract]   [Full Text] [Related]  

  • 35. Ideal treatment of portal hypertension in 1985.
    Conn HO
    Clin Gastroenterol; 1985 Jan; 14(1):259-88. PubMed ID: 3886215
    [No Abstract]   [Full Text] [Related]  

  • 36. Optimal use of propranolol in portal hypertension.
    Cales P
    Gastroenterol Clin Biol; 2005 Feb; 29(2):207-8. PubMed ID: 15803523
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk of hepatic encephalopathy in patients taking propranolol for portal hypertension.
    Reding P
    Lancet; 1982 Sep; 2(8297):550. PubMed ID: 6125697
    [No Abstract]   [Full Text] [Related]  

  • 38. [Propranolol and haemangiomas].
    López Gutiérrez JC
    An Pediatr (Barc); 2009 Nov; 71(5):461. PubMed ID: 19818697
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial: metformin for portal hypertension-old dog, new tricks?
    Palaniyappan N; Fallowfield JA
    Aliment Pharmacol Ther; 2021 Aug; 54(3):345-346. PubMed ID: 34236093
    [No Abstract]   [Full Text] [Related]  

  • 40. Reply: To PMID 24259407.
    Verbeke L; Trebicka J; Laleman W
    Hepatology; 2014 Nov; 60(5):1799-800. PubMed ID: 24623183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.